Canadian Antimicrobial Innovation Coalition (CAIC)

ICYMI: In honour of World Antimicrobial Resistance (AMR) Awareness Week (WAAW) 2024, CAIC's AMR Action Podcast welcomed guest speaker Damiano de Felice, Chief of External Affairs at CARB-X. This year’s WAAW theme is “Educate. Advocate. Act now.” In alignment with this theme, Damiano spoke about his work to advance conversations with governments around policies and actions needed to address AMR. He shares his insights from the Government of Italy’s recent investments in AMR and his ideas on how the Canadian government can prepare for its upcoming G7 presidency to enhance countries’ commitments to AMR. Tune in: tinyurl.com/AMRaction14 #WAAW2024 #AntimicrobialResistance #Innovation

CARB-X Chief of External Affairs Damiano de Felice joined the AMR Action Podcast for this World Antimicrobial Resistance (AMR) Awareness Week! Damiano reflects on Canada’s upcoming #G7 presidency: As a champion for #GlobalHealth, #Canada has a key opportunity to advance countries’ commitments to #AMR. Tune in to the full episode now on Apple Podcasts and Spotify. https://lnkd.in/gCfEF7yX #WAAW2024

Ahead of Canada’s #G7 presidency in 2025, Damiano de Felice, CARB-X, shares his perspective on how #Canada can help advance countries’ commitments to addressing #AntimicrobialResistance. Tune in to the #AMR Action Podcast on Apple Podcasts and Spotify to hear more: https://lnkd.in/gCfEF7yX #WAAW2024

Today at the AMR Symposium co-hosted by bioMérieux & University of Toronto's Emerging and Pandemic Infections Consortium in Toronto, CAIC Senior Advisor Danielle P. joined AMR Action Fund CEO Henry Skinner and Dr. Peter Daley, Associate Professor of Medicine - Infectious Diseases, Memorial University, Newfoundland and Labrador, AMMI Canada, for a panel entitled: "Delivering on Domestic and International AMR Priorities" with opening remarks from Dr. Kanchana Amaratunga MD, MPH, FRCPC, Director of Stewardship and Medical Advisor for the AMR Task Force, Public Health Agency of Canada | Agence de la santé publique du Canada. The panel discussed the importance of Canada’s leadership on #AMR and embracing #innovation in advance of Canada’s #G7 Presidency. “Going beyond access and rewarding #innovation is important to Canada’s leadership in the use and adoption of antibiotics diagnostics, medical devices and antimicrobial alternatives,” explained Dani. CAIC also joined AMR Action Fund & Sepsis Canada for a tour of bioMérieux's Critical Care Truck showcasing medical diagnostics to support #AntimicrobialStewardship, parked outside of Toronto City Hall. #WAAW2024 #AntimicrobialResistance #AMR #Canada #G7

On CAIC's #AMR Action Podcast, Damiano de Felice, CARB-X, shares his experience working with the Italian government to help implement push and pull incentives to accelerate research and development of new #antimicrobials. Tune in to the full episode on Apple Podcasts or Spotify! https://lnkd.in/gCfEF7yX #WAAW2024 #G7 #AntimicrobialResistance

In honour of #WAAW2024, guest speaker Damiano de Felice of CARB-X joins the #AMR Action Podcast! Damiano shares how governments can address #AntimicrobialResistance, including #Italy’s recent investments to support the development of innovative products. Tune in: https://lnkd.in/gCfEF7yX

Thank you Bob Rae for representing #Canada at the recent High-Level Meeting on #AMR during the #UNGA. The approved political declaration recognizes the importance of incentivizing innovation and financing national action plans to counter AMR in Canada and countries around the world. We look forward to working with Canadian officials and our global counterparts in upcoming discussions at the G7 and G20. Hon. Mark Holland, PC, MP Public Health Agency of Canada | Agence de la santé publique du Canada Read the Political Declaration of the High-level Meeting on Antimicrobial Resistance: https://lnkd.in/e-PzchgP

Check out World Health Organization’s latest policy brief: Antibacterial pipeline trends and recommendations to enhance research and development https://lnkd.in/gu_j9xtU Key points: ?? The antibacterial pipeline is highly fragile. Ninety-three per cent of developers at clinical stage are small biotechnology companies, while vast majority (86.7%) of developers at preclinical are very small, privately funded with limited resources. ?? There is a continued need for innovative new drugs to combat extensively resistant Gram-negative bacteria. ?? More antibacterial oral formulation options are needed. ?? More support is needed in developing non-traditional agents.

CAIC member Gilly Regev, CEO of SaNOtize Research and Development Corp. is presenting at the Military Health System Research Symposium in Orlando on ‘Strategies for Mitigating the Development of Post Traumatic Wound Infections’ #MHSRS2024

Congratulations to CAIC member Nosotech inc. on being awarded a contract with Resah “for its Nosokos and Antibiokos software for infection surveillance and alerts, monitoring antibiotic consumption and bacterial resistance to antibiotics, and antibiotic therapy monitoring.” https://lnkd.in/gBEiH7YC